PTK2 and ovarian carcinoma: Neutralizing antibodies against β1 and α3 integrin subunits could inhibit collagen I-induced activation of the FAK/ERK pathway in ovarian cancer cell lines [37]; however, enhanced activation of β1 integrin promotes phosphorylation of FAK, as seen in studies examining human lung fibroblasts viability [38-40].